06 February 2023

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

06 February 2023 | n=67

  1. Hill LA, Abulhosn KK, Yin JF, Bamford LP, et al.
    Single center experience evaluating and initiating people with HIV on long-acting cabotegravir/rilpivirine.
    AIDS 2022.

  2. Shakil SS, Temu TM, Kityo C, Nazzinda R, et al.
    Sex modulates the association between inflammation and coronary atherosclerosis among older Ugandan adults with and without HIV.
    AIDS 2022.

  3. Chastain DB, Motoa G, Ortiz-Martinez Y, Gharamti AE, et al.
    Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: A retrospective cohort.
    AIDS 2022.

  4. Jao J, Kacanek D, Broadwell C, Jacobson DL, et al.
    Gestational weight gain in persons living with HIV in the United States: results from the PHACS SMARTT study.
    AIDS 2022.

  5. Nikoloski Z, King EJ, Mosialos E.
    Human immunodeficiency virus in the Russian Federation: mortality, prevalence, risk factors, and current understanding of sexual transmission.
    AIDS 2022.

  6. Ong JJ, Booton RD, Tucker JD, Tang W, et al.
    Economic evaluation of improving HIV self-testing among men who have sex with men in China using a crowdsourced intervention: a cost-effectiveness analysis.
    AIDS 2022.

  7. Sadinski LM, Westreich D, Edmonds A, Breger TL, et al.
    Hypertension and one-year risk of all-cause mortality among women with treated HIV in the United States.
    AIDS 2022.

  8. Crothers K, Nance RM, Whitney BM, Harding BN, et al.
    Copd And The Risk For Myocardial Infarction By Type In People With Hiv.
    AIDS 2022.

  9. Henderson ER, Haberlen SA, Coulter RWS, Weinstein AM, et al.
    The role of social support on cognitive function among midlife and older adult men who have sex with men.
    AIDS 2022.

  10. Mazaheri T, Buchanan D, Hung R, Campbell L, et al.
    Creatinine and cystatin C-based eGFR estimate of kidney function in black people with HIV on antiretroviral therapy.
    AIDS 2022.

  11. Rajasuriar R, Li CM, Ross JL, Jiamsakul A, et al.
    Factors associated with reduced function and quality of life among adult plwh with depression and substance use in the asia-pacific region.
    AIDS 2022.

  12. Mugo C, Kohler P, Kumar M, Badia J, et al.
    Effect of HIV stigma on depressive symptoms, treatment adherence, and viral suppression among youth with HIV.
    AIDS 2022.

  13. Zhou S, Qi K, Nugent BM, Bersoff-Matcha SJ, et al.
    Participation of HIV-1 infected treatment-naive females in clinical trials and sex differences in efficacy and safety outcomes.
    AIDS 2023.

  14. Rukuni R, Victoria S, Rehman AM, Mukwasi-Kahari C, et al.
    Fracture prevalence and its association with bone density among children living with HIV in Zimbabwe.
    AIDS 2023.

  15. Byers BW, Drak D, Shamu T, Chimbetete C, et al.
    Assessing Renal Impairment in Treatment-Naive Adolescents Living with HIV Commencing Antiretroviral Therapy In Zimbabwe.
    AIDS 2023.

  16. Mauas R, Urena A, Cecchini D, Strada ML, et al.
    Adverse events and SARS-CoV-2 antibody responses after immunization with sputnik V, ChAdOx1-S and BBIBP-CorV vaccines in people with HIV.
    AIDS 2023.

  17. Bowman C, Ambrose A, Kanitkar T, Flores K, et al.
    Real world use of dolutegravir two drug regimens.
    AIDS 2023.

  18. Neufeld B, Cholette F, Sandstrom P, Musyoki H, et al.
    HIV acquisition prior to entry into formal sex work: inference from next-generation viral sequencing.
    AIDS 2023.

  19. Mamidi RS, Ayubcha C, Rigney G, Kirschner J, et al.
    A prospective 18F-FDG PET/CT study of the neurometabolic effects in cocaine use and HIV infection.
    AIDS 2023.

  20. Zewdie K, Pickles M, Floyd S, Fidler S, et al.
    Uptake of medical male circumcision with household-based testing, and the association of traditional male circumcision and HIV infection.
    AIDS 2023.

  21. Van Ommen CE, Hsieh AYY, Albert AY, Kimmel ER, et al.
    Lower anti-mullerian hormone levels are associated with HIV in reproductive age women and shorter leukocyte telomere length among late reproductive age women.
    AIDS 2023.

  22. Neary J, Fish CS, Cassidy NA, Wamalwa D, et al.
    Predictors of intact HIV DNA levels among children in Kenya.
    AIDS 2023.

  23. Mazzitelli M, Trunfio M, Milinkovic A, Castelli E, et al.
    Sleep disturbances and their correlation with cardiovascular risk, obesity, and mood disorders in people living with HIV.
    AIDS 2023.

  24. Rao A, Lesko C, Mhlophe H, Rucinski K, et al.
    Longitudinal patterns of initiation, persistence, and cycling on PrEP among female sex workers and adolescent girls and young women in South Africa, 2016-2021.
    AIDS 2023.

  25. Arrigoni FIF, Spyer M, Hunter P, Alber D, et al.
    Impact of sub-optimal HIV viral control on activated T-cells: an earnest sub study.
    AIDS 2023.

  26. Yang X, Zhang J, Chen S, Weissman S, et al.
    The impact of COVID-19 pandemic on the dynamic HIV care engagement among people with HIV: real-world evidence.
    AIDS 2023.

  27. Bolzenius J, Sacdalan C, Ndhlovu LC, Sailasuta N, et al.
    Brain volumetrics differ by fiebig stage in acute HIV infection.
    AIDS 2023.

  28. Fonner VA, Ridgeway K, Van Der Straten A, Lorenzetti L, et al.
    Safety and efficacy of long-acting injectable cabotegravir as pre-exposure prophylaxis to prevent HIV acquisition: a systematic review and meta-analysis.
    AIDS 2023.

  29. Ruderman SA, Nance RM, Drumright LN, Whitney BM, et al.
    Development of frail RISC-HIV: a risk score for predicting frailty risk in the short-term for care of people with HIV.
    AIDS 2023.

  30. Oomen PGA, Hakkers CS, Arends J, van den Berk G, et al.
    The effect of efavirenz on reward processing in asymptomatic people living with HIV: a randomized controlled trial.
    AIDS Res Hum Retroviruses 2023.

  31. Oliver SE, Rubis AB, Soeters HM, Reingold A, et al.
    Epidemiology of invasive nontypeable Haemophilus influenzae disease-United States, 2008-2019.
    Clin Infect Dis 2023.

  32. Sangare MN, Baril JG, de Pokomandy A, Klein M, et al.
    CD4/CD8 ratio outcome according to the class of the third active drug in antiretroviral therapy (ART) regimens: results from the Quebec Human Immunodeficiency Virus (HIV) Cohort Study.
    Clin Infect Dis 2023.

  33. Paulsen FW, Tetens MM, Vollmond CV, Gerstoft J, et al.
    Incidence of childbirth, pregnancy, spontaneous abortion, and induced abortion among women with Human Immunodeficiency Virus (HIV), a nationwide matched cohort study.
    Clin Infect Dis 2023.

  34. Govind A, Lazarte SM, Kitchell E, Chow JY, et al.
    Severe Mpox Infections in People with Uncontrolled Human Immunodeficiency Virus (HIV).
    Clin Infect Dis 2023.

  35. Molldrem S.
    Research on the Development of SARS-CoV-2 Variants of Concern in People with Advanced HIV Disease Should Highlight Structural Conditions and Avoid Harmful Stereotypes.
    Clin Infect Dis 2023.

  36. Suran M.
    New HIV Vaccine Approach Safely Stimulated Rare Precursors to Broadly Neutralizing Antibodies.
    JAMA 2023.

  37. El-Nahal WG, Chander G, Jones JL, Fojo AT, et al.
    Telemedicine Use Among People with HIV in 2021: The Hybrid-Care Environment.
    J Acquir Immune Defic Syndr 2022.

  38. Gurley SA, Stupp PW, Fellows IE, Parekh BS, et al.
    Estimation of HIV-1 Incidence Using a Testing History-Based method; analysis from the Population-based HIV Impact Assessment survey data in 12 African Countries.
    J Acquir Immune Defic Syndr 2022.

  39. Kalichman SC, Eaton LA, Kalichman MO, Sam SS, et al.
    Pre-Pandemic Predictors of Medication Adherence and HIV Viral Load During the First Year of COVID-19.
    J Acquir Immune Defic Syndr 2022.

  40. Lindsey JC, Hudgens M, Gaur AH, Horvath KJ, et al.
    Electronic dose monitoring device patterns in youth living with HIV enrolled in an adherence intervention clinical trial.
    J Acquir Immune Defic Syndr 2022.

  41. Ajibola G, Maswabi K, Hughes MD, Bennett K, et al.
    Long-term clinical, immunologic, and virologic outcomes among early-treated children with HIV in Botswana: a nonrandomized controlled clinical trial.
    J Acquir Immune Defic Syndr 2022.

  42. Cottino MC, Kulig CE, Suh JS, Jimenez HR, et al.
    Evaluation of Statin Prescribing Practices and Predictors of Statin Underutilization in Persons with HIV.
    J Acquir Immune Defic Syndr 2022.

  43. Stoner MCD, Kelly NK, Gomez-Olive FX, Kahn K, et al.
    The relationships among stress-responsive biomarkers, ART adherence, and viral suppression among adolescent girls and young women living with HIV in South Africa: An HPTN 068 Analysis.
    J Acquir Immune Defic Syndr 2022.

  44. Torre P 3rd, Zhang ZJ, Hoffman HJ, Frederick T, et al.
    Auditory Function in the Pediatric HIV/AIDS Cohort Study Adolescent Master Protocol (AMP) Up Young Adults: A Pilot Study.
    J Acquir Immune Defic Syndr 2022.

  45. Wembulua BS, Valin N, Lambert-Niclot S, Nerozzi-Banfi E, et al.
    APOBEC-induced mutations at initiation of cabotegravir + rilpivirine for two patients infected by HIV-1 subtype CRF02: The interest of systematic genotyping.
    J Acquir Immune Defic Syndr 2022.

  46. Govender T, Jham MA, Zhang JC, Pillay S, et al.
    Decentralized, integrated treatment of RR/MDR-TB and HIV using a bedaquiline-based, short regimen is effective and associated with improved HIV disease control.
    J Acquir Immune Defic Syndr 2022.

  47. Irvine MK, Levin B, Abdelqader F, Carmona J, et al.
    Evaluation of the revised versus original Ryan White Part A HIV Care Coordination Program in a cluster-randomized, stepped-wedge trial.
    J Acquir Immune Defic Syndr 2022.

  48. Antoine M, Rubenstein E, Lascoux C, Chawki S, et al.
    Clinical description of sixty-six cases of monkeypox virus (MKPV) infection among men who have sex with men (MSM), in an HIV/PrEP French Clinic.
    J Acquir Immune Defic Syndr 2022.

  49. Askari A, Nashier C, Ghelani R, Zhang AV, et al.
    Switching to high genetic-barrier integrase inhibitors reduces drug-drug interactions in people living with HIV.
    J Acquir Immune Defic Syndr 2022.

  50. Miller MJ, Eberhart LG, Jefferson CR, Horberg MA, et al.
    Beyond Antiretroviral Treatment: Patterns and Factors Associated with Composite Medication Adherence Before and During the COVID-19 Pandemic in Patients with HIV with Multiple Chronic Conditions.
    J Acquir Immune Defic Syndr 2022.

  51. Ganesan K, Mwesigwa R, Dear N, Esber AL, et al.
    EPIDEMIOLOGY OF TUBERCULOSIS AMONG PEOPLE LIVING WITH HIV IN THE AFRICAN COHORT STUDY FROM 2013-2021.
    J Acquir Immune Defic Syndr 2023.

  52. Liang C, Suen SC, Nguyen A, Moucheraud C, et al.
    The Impact of COVID-19 Response on the HIV Epidemic in Men Who Have Sex with Men in San Francisco County: The Importance of Rapid Return to Normalcy.
    J Acquir Immune Defic Syndr 2023.

  53. Stoner MCD, Browne EN, Kabudula C, Rosenberg M, et al.
    The effects of participation in an intensive HIV prevention trial on long term socio-demographic outcomes among young women in rural South Africa.
    J Acquir Immune Defic Syndr 2023.

  54. Black DA, LaCourse SM, Njuguna IN, Beima-Sofie KM, et al.
    Tuberculosis preventative therapy initiation and completion among adolescents and young adults with HIV in Kenya.
    J Acquir Immune Defic Syndr 2023.

  55. Jacobs TG, Mumbiro V, Chitsamatanga M, Namuziya N, et al.
    Suboptimal lopinavir exposure in infants on rifampicin treatment receiving double-dosed or semi-superboosted lopinavir/ritonavir: time for a change.
    J Acquir Immune Defic Syndr 2023.

  56. Yee WH, Li WP, Bador MK, Li CM, et al.
    Poor HIV-Related Outcomes In Older Adults Newly Diagnosed with HIV: A Four-Year Retrospective Analysis from A Single Site in Asia.
    J Acquir Immune Defic Syndr 2023.

  57. Hrapcak S, Hast M, Okegbe T, Gross J, et al.
    The status of adolescent testing and treatment in PEPFAR-supported programs, October 2017-September 2020.
    J Acquir Immune Defic Syndr 2023.

  58. Kennedy BD, Blazkova J, Justement JS, Shi V, et al.
    Comprehensive analysis of HIV reservoirs in elite controllers.
    J Clin Invest 2023;133.

  59. Li P, Li J, Ayada I, Avan A, et al.
    Clinical features, antiviral treatment and patient outcomes: a systematic review and comparative analysis of the previous and the 2022 mpox outbreaks.
    J Infect Dis 2023.

  60. Not A, Saludes V, Galvez M, Miralpeix A, et al.
    Usefulness of dried blood spot samples for monitoring hepatitis C treatment outcome and reinfection among people who inject drugs in a test-and-treat program.
    J Med Virol 2023.

  61. Torre-Tarazona E, Gonzalez-Robles A, Cascajero A, Jimenez P, et al.
    Treatment with integrase inhibitors alters SARS-CoV-2 neutralization levels measured with HIV-based pseudotypes in people living with HIV.
    J Med Virol 2023.

  62. Ferre VM, Bitty-Anderson AM, Peytavin G, Le MP, et al.
    Pharmaco-virological algorithm to target risk of drug resistance among a population of HIV-infected key populations in Togo.
    J Med Virol 2023.

  63. Pan D, Nazareth J, Sze S, Martin CA, et al.
    Transmission of Mpox: A narrative review of environmental, viral, host and population factors in relation to the 2022 international outbreak.
    J Med Virol 2023.

  64. Duran-Castells C, Llano A, Kawana-Tachikawa A, Prats A, et al.
    Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.
    J Virol 2023.

  65. Mukim A, Smith DM, Deshmukh S, Qazi AA, et al.
    A Camptothetin Analog, Topotecan, Promotes HIV Latency via Interference with HIV Transcription and RNA Splicing.
    J Virol 2023.

  66. Eke AC, Mirochnick M, Lockman S.
    Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV.
    N Engl J Med 2023;388:344-356.

  67. Hrapcak S, Pals S, Itoh M, Peters N, et al.
    HIV Viral Load Scale-up Among Children and Adolescents: Trends in Viral Load Suppression, Sample Type and Processing in 7 PEPFAR Countries, 2015-2018.
    Pediatr Infect Dis J 2023.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

06 February 2023

30 January 2023

23 January 2023

16 January 2023

09 January 2023


06 February 2023

Multidisciplinary Journal Club

  1. Porsbjerg C, Melen E, Lehtimaki L, Shaw D, et al.
    Asthma.
    Lancet. 2023 Jan 19:S0140-6736(22)02125-0. doi: 10.1016/S0140-6736(22)02125.

  2. Reinecke H, Engelbertz C, Bauersachs R, Breithardt G, et al.
    A Randomized Controlled Trial Comparing Apixaban to the Vitamin K-antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 study.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062779.

  3. Shapiro NI, Douglas IS, Brower RG, Brown SM, et al.
    Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.
    N Engl J Med. 2023 Jan 21. doi: 10.1056/NEJMoa2212663.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016